SOPH
Sophia Genetics SANASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$348.31M
P/E Ratio
—
EPS
$-1.16
Beta
1.04
52W High
$5.70
52W Low
$2.58
50-Day MA
$4.80
200-Day MA
$4.23
Dividend Yield
—
Profit Margin
-102.20%
Forward P/E
—
PEG Ratio
—
About Sophia Genetics SA
Sophia Genetics SA (SOPH) is a pioneering leader in data-driven medicine, focusing on advanced genomic and clinical data analytics that enhance patient outcomes. Utilizing cutting-edge machine learning algorithms, the company provides a comprehensive platform that aids hospitals and laboratories in interpreting complex genomic data, thus facilitating personalized treatment strategies, especially in oncology, rare diseases, and hereditary disorders. With a strong international footprint and strategic partnerships with premier healthcare organizations, Sophia Genetics is committed to transforming healthcare through precision medicine, solidifying its position as a front-runner in the genomics landscape.
Fundamentals
| Revenue (TTM) | $77.27M |
| Gross Profit (TTM) | $52.08M |
| EBITDA | $-69.17M |
| Operating Margin | -85.40% |
| Return on Equity | -110.00% |
| Return on Assets | -27.90% |
| Revenue/Share (TTM) | $1.14 |
| Book Value | $0.69 |
| Price-to-Book | 7.67 |
| Price-to-Sales (TTM) | 4.51 |
| EV/Revenue | 4.585 |
| EV/EBITDA | -0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.40% |
| Shares Outstanding | $71.67M |
| Float | $52.55M |
| % Insiders | 8.61% |
| % Institutions | 47.65% |
Historical Volatility
HV 10-Day
44.10%
HV 20-Day
46.44%
HV 30-Day
54.37%
HV 60-Day
50.23%
HV Rank
34.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.67 target)
4
BuyData last updated: 4/9/2026